foxo4-dri itch Development of a novel senolytic by precise disruption of FOXO4-p53 complex The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI 10mg Research Peptide Amino USA Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link PI3K Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3K Syndrome and Beyond The Journal of Allergy and Clinical Immunology: In Practice FOXO4 DRI Results: What to Expect (2026)
Pay in 4 interest-free payments of $6.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20




